Christie acquires Luminetx

Christie, a visual technologies company, has acquired all the assets of Luminetx, a medical biosciences technology company.

The assets include Luminetx’ technology and intellectual property for the vascular imaging system, VienViewer. Christie will create a new medical products business operating under Christie Medical Holdings.

“Christie’s goal is to diversify into emerging markets and we saw...[an] opportunity to enter the medical imaging industry,” said George Pinho, president of Christie Medical.

Michael Bassett,

Contributor

Around the web

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.